Ginkgo Bioworks Holdings Inc (DNA) stock is down -63.96% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives DNA stock a score of 35 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. DNA’s rank also includes a long-term technical score of 10.
What’s Happening with DNA Stock Today
Ginkgo Bioworks Holdings Inc (DNA) stock has risen 2.14% while the S&P 500 is down -0.31% as of 11:13 AM on Tuesday, Jan 17. DNA is higher by $0.04 from the previous closing price of $1.87 on volume of 8,139,850 shares. Over the past year the S&P 500 has fallen -12.90% while DNA is down -63.96%. DNA lost -$2.23 per share in the over the last 12 months.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
I have been writing professionally for over 20 years and have a deep understanding of the psychological and emotional elements that affect people. I’m an experienced ghostwriter and editor, as well as an award-winning author of five novels.